Interactions have not been studied.

They need to know if you have any of these conditions:

-heart disease
-infection especially a viral infection such as chickenpox, cold sores, herpes, or hepatitis B
-lung or breathing disease
-an unusual or allergic reaction to daratumumab, hyaluronidase, other medicines, foods, dyes, or preservatives
-pregnant or trying to get pregnant
-breast-feeding

Your condition will be monitored carefully while you are receiving this medicine.
This medicine can cause serious allergic reactions. To reduce your risk, your health care provider may give you other medicine to take before receiving this one. Be sure to follow the directions from your health care provider.
This medicine can affect the results of blood tests to match your blood type. These changes can last for up to 6 months after the final dose. Your healthcare provider will do blood tests to match your blood type before you start treatment. Tell all of your healthcare providers that you are being treated with this medicine before receiving a blood transfusion.
This medicine can affect the results of some tests used to determine treatment response; extra tests may be needed to evaluate response.
Do not become pregnant while taking this medicine or for 3 months after stopping it. Women should inform their health care provider if they wish to become pregnant or think they might be pregnant. There is a potential for serious side effects to an unborn child. Talk to your health care provider for more information. Do not breast-feed an infant while taking this medicine.

This drug is given in a hospital or clinic and will not be stored at home.